Threats and outbreaks of listeriosis

Publication

Communicable disease threats report, 17-23 February 2019, week 8

publication -

Publication

Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – third update

risk assessment -

Publication

Communicable disease threats report, 3-9 February 2019, Week 6

surveillance report -

Publication

Communicable disease threats report, 27 January-2 February 2019, Week 5

publication -

Publication

Communicable Disease Threats Report, 20-26 January 2019, week 4

surveillance report -

News

Epidemiological update: multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6 infections

epidemiological update -

News

Epidemiological update: Multi-country outbreak of Listeria monocytogenes PCR serogroup IVb, MLST 6

epidemiological update -

Publication

Communicable disease threats report, 17-23 February 2019, week 8

publication -

Publication

Communicable disease threats report, 10-16 February 2019, Week 7

publication -

Publication

Communicable disease threats report, 3-9 February 2019, Week 6

surveillance report -

Publication

Communicable disease threats report, 27 January-2 February 2019, Week 5

publication -

Publication

Communicable Disease Threats Report, 20-26 January 2019, week 4

surveillance report -

Publication

Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products

risk assessment -

Publication

Rapid risk assessment: Multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6, infections linked to frozen corn and possibly to other frozen vegetables – first update

risk assessment -

Publication

Rapid risk assessment: Multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6, infections probably linked to frozen corn

risk assessment -

Publication

Rapid risk assessment: Multi-country outbreak of Listeria monocytogenes PCR serogroup IVb, MLST ST6

risk assessment -